In vitro research using murine BV2 microglial cells demonstrated that conditioned media from glioma cells might activate microglial cells by increasing the mRNA levels of cyclooxygenase-2 (COX-2), tumor TNF-α, IL-6, iNOS, and IL-1β. Here, PTGS2 is linked to central nervous system cancer.